Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Adalimumab significantly improved symptoms and quality of life in two patients with Hidradenitis Suppurativa.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

Scalp itching is common and hard to diagnose due to the complex nerve structure of the scalp.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Hair cortisol could be a marker for chronic stress in pregnancy, but depression affects cortisol levels differently.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Pannexin 3 is important for bone formation and the development of bone cells.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

More people were diagnosed with certain skin diseases and sexually transmitted diseases in 2014 compared to 2003 in a Brazilian public institution.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Potential new drugs for treating PCOS were identified.

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The transfollicular route shows promise for noninvasive, targeted drug delivery but needs more research.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.